Kymera Therapeutics Ownership | Who Owns Kymera Therapeutics?
Kymera Therapeutics Ownership Summary
Kymera Therapeutics is owned by 93.47% institutional investors, 1.31% insiders, and 5.22% retail investors. Price t rowe associates inc /md/ is the largest institutional shareholder, holding 9.03% of KYMR shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 4.78% of its assets in Kymera Therapeutics shares.
KYMR Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Kymera Therapeutics | 93.47% | 1.31% | 5.22% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Price t rowe associates inc /md/ | 6.87M | 9.03% | $276.39M |
Baker bros. advisors lp | 6.00M | 7.88% | $241.22M |
Wellington management group llp | 5.31M | 6.97% | $213.51M |
Bvf inc/il | 5.16M | 6.78% | $207.66M |
Avoro capital advisors | 5.15M | 6.77% | $207.18M |
Atlas venture life science advisors | 4.90M | 6.43% | $196.98M |
Vanguard group | 4.89M | 6.42% | $196.62M |
Fmr | 4.83M | 6.35% | $194.33M |
Blackrock | 4.16M | 5.87% | $124.04M |
Blackrock funding, inc. /de | 4.36M | 5.72% | $175.25M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Atlas venture life science advisors | 4.90M | 24.03% | $196.98M |
Merck | 772.16K | 12.04% | $31.06M |
Aquilo capital management | 183.52K | 11.13% | $7.38M |
Bvf inc/il | 5.16M | 7.04% | $207.66M |
Siren | 2.97M | 5.28% | $119.47M |
Redmile group | 1.10M | 3.09% | $44.27M |
Avoro capital advisors | 5.15M | 2.93% | $207.18M |
Foresite capital management vi | 146.33K | 2.62% | $5.89M |
Baker bros. advisors lp | 6.00M | 2.58% | $241.22M |
Artal group | 3.01M | 2.29% | $89.72M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Merck | 772.16K | 12.04% | 772.16K |
Wellington management group llp | 5.31M | 0.04% | 688.97K |
Avoro capital advisors | 5.15M | 2.93% | 650.00K |
Deerfield management company, l.p. (series c) | 593.00K | 0.45% | 593.00K |
Blackrock | 4.16M | 0.00% | 499.77K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Deep track capital, lp | - | - | -600.33K |
Redmile group | 1.10M | 3.09% | -292.82K |
Fmr | 4.83M | 0.01% | -278.72K |
Frontier capital management | 150.17K | 0.06% | -242.09K |
Great lakes advisors | - | - | -156.38K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Merck | 772.16K | 12.04% | 772.16K | $31.06M |
Deerfield management company, l.p. (series c) | 593.00K | 0.45% | 593.00K | $23.86M |
Ecor1 capital | 350.00K | 0.53% | 350.00K | $14.08M |
Foresite capital management vi | 146.33K | 2.62% | 146.33K | $5.89M |
Soros fund management | 120.37K | 0.07% | 120.37K | $4.84M |
Sold Out
Holder | Change |
---|---|
Financial gravity asset management | -2.00 |
Capital performance advisors llp | -3.00 |
Riggs asset managment | -7.00 |
Nelson, van denburg & campbell wealth management group | -8.00 |
Cva family office | -12.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 180 | -0.55% | 71,156,642 | 3.18% | 93 | 1.14% | 88 | -4.35% | 59 | -4.84% |
Sep 30, 2024 | 181 | 16.03% | 68,964,551 | 2.37% | 90 | 1.00% | 93 | 6.90% | 62 | 31.91% |
Jun 30, 2024 | 155 | -4.32% | 67,367,833 | 0.44% | 95 | 0.72% | 86 | -14.85% | 47 | 11.90% |
Mar 31, 2024 | 162 | 20.00% | 67,073,034 | 11.04% | 114 | 1.07% | 101 | 48.53% | 42 | -17.65% |
Dec 31, 2023 | 135 | 10.66% | 60,406,777 | 5.38% | 103 | 1.07% | 68 | 11.48% | 51 | 45.71% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
US Small-Cap Growth II Equity Comp | 3.09M | 4.78% | -46.89K |
T. Rowe Price New Horizons | 3.09M | 4.76% | - |
Vanguard Health Care Inv | 2.35M | 3.63% | 525.72K |
Fidelity Growth Compy Commingled Pl O | 2.24M | 3.46% | 52.60K |
Fidelity Growth Compy Commingled Pl S | 1.93M | 2.97% | -250.03K |
Vanguard US Total Market Shares ETF | 1.54M | 2.38% | 1.91K |
Vanguard Total Stock Mkt Idx Inv | 1.54M | 2.37% | 1.66K |
Fidelity Growth Company Fund | 1.35M | 2.07% | -196.90K |
Vanguard Small Cap Index | 1.24M | 1.91% | 1.01K |
iShares Russell 2000 ETF | 1.24M | 1.91% | -10.72K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 03, 2025 | Chiniara Ellen | Chief Legal Officer | Sell | $55.59K |
Mar 03, 2025 | Chiniara Ellen | Chief Legal Officer | Sell | $12.65K |
Mar 03, 2025 | Chadwick Jeremy G | Chief Operating Officer | Sell | $34.30K |
Mar 03, 2025 | Chadwick Jeremy G | Chief Operating Officer | Sell | $7.81K |
Mar 03, 2025 | Jacobs Bruce N. | Chief Financial Officer | Sell | $174.50K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | - |
2025 Q1 | - | 9 |
2024 Q4 | - | 1 |
2024 Q3 | 5 | 16 |
2024 Q2 | - | 9 |
KYMR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools